Efficacy and safety of glucocorticoids in community-acquired pneumonia; a systematic review and metaanalysis of randomized controlled trials

Chinese Journal of Emergency Medicine

Volumn 23, Issue 1, 2014, Pages 65-70

  Chen, Liping ^a   Chen, Junhui ^a   Chen, Ying ^a   Wu, Chao ^a   Yang, Xiaohong ^a  

^a Xinjiang Autonomous Region People Hospital   (China)

Author keywords

Community acquired pneumonia; Glucocorticoids; Meta analysis

Indexed keywords

EID: 84897819190     PISSN: 16710282     EISSN: None     Source Type: Journal    
DOI: 10.3760/cma.j.issn.1671-0282.2014.01.016     Document Type: Review

References (13)

1. Sibilant O, Agusti C, Torres A. Corticosteroids in severe pneumonia [J]. Eur Respir J, 2008, 32 (2): 259-264.
2. Anderson RN, Smith BL. Deaths: leading causes for 2002 [J]. Natl Vital State Rep, 2005, 53 (17): 1-89.
3. Mandeli LA, Wunderink RG, Anzueto A, et al. Infectious Diseases Society of America/American Thoracic Society consensus guidelines on the management of community-acquired pneumonia in adults [ J ]. Clin Infect Dis, 2007, 44Suppl 2: S27-72. (Pubitemid 46290553)
4. Niederman MS. Recent advances in community-acquired pneumonia inpatient and outpatient [J]. Chest, 2007, 131 (4) : 1205-1215. (Pubitemid 46608726)
5. Annane D, Maxime V, Ibrahim F, et al. Diagnosis of adrenal insufficiency in severe sepsis and septic shock [J]. Am J Respir Crit Care Med, 2006, 174 (12) : 1319-1326. (Pubitemid 44913033)
6. de Jong MF, Beishuizen A, Spijkstra JJ, et al. Relative adrenal insufficiency as a predictor of disease severity, mortality, and beneficial effects of corticosteroid treatment in septic shock [ J ]. Crit Care Med, 2007, 35 (8): 1896-1903. (Pubitemid 47220364)
7. Campbell SG, Mclvor RA, Joanis V, et al. Can we predict which patients with community-acquired pneumonia are likely to have positive blood cultures? [J]. World J Emerg Med, 2011,2 (4) : 272-278.
8. Remmelts HH, Meijvis SC, Heijligenberg R, et al. Biomarkers define the clinical response to dexamethasone in community-acquired pneumonia [J]. J Infect, 2012, 65 (1): 25-31.
9. Confalonieri M, Urbino R, Potena A, et al. Hydrocortisone infusion for severe community-acquired pneumonia: a preliminary randomized study [J]. Am J Respir Crit Care Med, 2005, 171 (3) : 242-248.
10. Xie J, Lu YM, Jin - dong Shi JD, et al. Visfatin levels in patients with severe pneumonia [J]. World J Emerg, 2011, 2 (2) : 132-136.
11. Marik PE, Pastores SM, Annane D, et al. Recommendations for the diagnosis and management of corticosteroid insufficiency in critically ill adult patients : consensus statements from an international task force by the American College of Critical Care Medicine [J]. Crit Care Med, 2008, 36 (6): 1937-1949.
12. Meijvis SC, Hardeman H, Remmelts HH, et al. Dexamethasone and length of hospital stay in patients with community-acquired pneumonia: a randomised, double-blind, placebo-controlled trial [ J ]. Lancet, 2011, 377 (9782): 2023-2030.
13. Fernández-Serrano, Jordi Dorca, Carolina Garcia-Vidal, et al. Effect of corticosteroids on the clinical course of community-acquired pneumonia: a randomized controlled trial [J]. Critical Care, 2011, 15 (2): R96.